Implantable cardioverter-defibrillator longevity under clinical circumstances: An analysis according to device type, generation, and manufacturer

Published:November 16, 2011DOI:


      One of the major drawbacks of implantable cardioverter-defibrillator (ICD) treatment is the limited device service life. Thus far, data concerning ICD longevity under clinical circumstances are scarce. In this study, the ICD service life was assessed in a large cohort of ICD recipients.


      To assess the battery longevity of ICDs under clinical circumstances.


      All patients receiving an ICD in the Leiden University Medical Center were included in the analysis. During prospectively recorded follow-up visits, reasons for ICD replacement were assessed and categorized as battery depletion and non–battery depletion. Device longevity and battery longevity were calculated. The impact of device type, generation, manufacturer, the percentage of pacing, the pacing output, and the number of shocks on the battery longevity was assessed.


      Since 1996, 4673 ICDs were implanted, of which 1479 ICDs (33%) were replaced. Mean device longevity was 5.0 ± 0.1 years. A total of 1072 (72%) ICDs were replaced because of battery depletion. Mean battery longevity of an ICD was 5.5 ± 0.1 years. When divided into different types, mean battery longevity was 5.5 ± 0.2 years for single-chamber ICDs, 5.8 ± 0.1 for dual-chamber ICDs, and 4.7 ± 0.1 years for cardiac resynchronization therapy–defibrillators (P <.001). Devices implanted after 2002 had a significantly better battery longevity as compared with devices implanted before 2002 (5.6 ± 0.1 years vs 4.9 ± 0.2 years; P <.001). In addition, large differences in battery longevity between manufacturers were noted (overall log-rank test, P <.001).


      The majority of ICDs were replaced because of battery depletion. Large differences in longevity exist between different ICD types and manufacturers. Modern ICD generations demonstrated improved longevity.



      ATP (antitachycardia pacing), CI (confidence interval), CRT-D (cardiac resynchronization therapy–defibrillator), ICD (implantable cardioverter-defibrillator)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
        A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
        N Engl J Med. 1997; 337: 1576-1583
        • Bardy G.H.
        • Lee K.L.
        • Mark D.B.
        • et al.
        Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
        N Engl J Med. 2005; 352: 225-237
        • Buxton A.E.
        • Lee K.L.
        • Fisher J.D.
        • Josephson M.E.
        • Prystowsky E.N.
        • Hafley G.
        • Multicenter Unsustained Tachycardia Trial Investigators
        A randomized study of the prevention of sudden death in patients with coronary artery disease.
        N Engl J Med. 1999; 341: 1882-1890
        • Connolly S.J.
        • Gent M.
        • Roberts R.S.
        • et al.
        Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone.
        Circulation. 2000; 101: 1297-1302
        • Hohnloser S.H.
        • Kuck K.H.
        • Dorian P.
        • et al.
        Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
        N Engl J Med. 2004; 351: 2481-2488
        • Kadish A.
        • Dyer A.
        • Daubert J.P.
        • et al.
        Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
        N Engl J Med. 2004; 350: 2151-2158
        • Kuck K.H.
        • Cappato R.
        • Siebels J.
        • Ruppel R.
        Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH).
        Circulation. 2000; 102: 748-754
        • Moss A.J.
        • Hall W.J.
        • Cannom D.S.
        • et al.
        • Multicenter Automatic Defibrillator Implantation Trial Investigators
        Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.
        N Engl J Med. 1996; 335: 1933-1940
        • Moss A.J.
        • Zareba W.
        • Hall W.J.
        • et al.
        Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
        N Engl J Med. 2002; 346: 877-883
        • Hauser R.G.
        The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators.
        J Am Coll Cardiol. 2005; 45: 2022-2025
        • Maisel W.H.
        • Moynahan M.
        • Zuckerman B.D.
        • et al.
        Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports.
        JAMA. 2006; 295: 1901-1906
        • Epstein A.E.
        • DiMarco J.P.
        • Ellenbogen K.A.
        • et al.
        ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2008; 51: e1-e62
        • Borleffs C.J.
        • Thijssen J.
        • de Bie M.K.
        • et al.
        Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications.
        Pacing Clin Electrophysiol. 2010; 33: 1013-1019
        • Reynolds M.R.
        • Cohen D.J.
        • Kugelmass A.D.
        • et al.
        The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators.
        J Am Coll Cardiol. 2006; 47: 2493-2497
        • Sanders G.D.
        • Hlatky M.A.
        • Owens D.K.
        Cost-effectiveness of implantable cardioverter-defibrillators.
        N Engl J Med. 2005; 353: 1471-1480
        • Zipes D.P.
        • Camm A.J.
        • Borggrefe M.
        • et al.
        ACC/AHA/ESC 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
        Circulation. 2006; 114: e385-e484
        • Knops P.
        • Theuns D.A.
        • Res J.C.
        • Jordaens L.
        Analysis of implantable defibrillator longevity under clinical circumstances: implications for device selection.
        Pacing Clin Electrophysiol. 2009; 32: 1276-1285
        • Hauser R.
        • Hayes D.
        • Parsonnet V.
        • et al.
        Feasibility and initial results of an Internet-based pacemaker and ICD pulse generator and lead registry.
        Pacing Clin Electrophysiol. 2001; 24: 82-87
        • Schaer B.A.
        • Koller M.T.
        • Sticherling C.
        • Altmann D.
        • Joerg L.
        • Osswald S.
        Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity.
        Heart Rhythm. 2009; 6: 1737-1743
        • Biffi M.
        • Ziacchi M.
        • Bertini M.
        • et al.
        Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.
        Europace. 2008; 10: 1288-1295
        • Ellinor P.T.
        • Guy M.L.
        • Ruskin J.N.
        • McGovern B.A.
        Variability in implantable cardioverter defibrillator pulse generator longevity between manufacturers.
        Pacing Clin Electrophysiol. 2003; 26: 71-75
        • Klug D.
        • Balde M.
        • Pavin D.
        • et al.
        Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study.
        Circulation. 2007; 116: 1349-1355
        • Lekkerkerker J.C.
        • van Nieuwkoop C.
        • Trines S.A.
        • et al.
        Risk factors and time delay associated with cardiac device infections: Leiden device registry.
        Heart. 2009; 95: 715-720
        • Wild D.M.
        • Fisher J.D.
        • Kim S.G.
        • Ferrick K.J.
        • Gross J.N.
        • Palma E.C.
        Pacemakers and implantable cardioverter defibrillators: device longevity is more important than smaller size: the patient's viewpoint.
        Pacing Clin Electrophysiol. 2004; 27: 1526-1529